Fig 1.
Optical coherence tomography scan of vitreomacular traction.
Optical coherence tomography overlapping (x50) line scans are used to exclude ERM.
Table 1.
Baseline demographics and ocular characteristics.
Table 2.
Baseline characteristics of individual patients and anatomical resolution of VMT at 4, 12 and 24 weeks.
Fig 2.
Case study of VMT and macular hole.
This 60 year old female patient was diagnosed with right VMT and FTMH (357 microns), she had suffered for 2–3 months with blurred and distorted vision and was very symptomatic, the absence of ERM was confirmed. Vision prior to ocriplasmin injection was R 6/36, L 6/18. The patient was treated with ocriplasmin according to standard MEH protocols and followed up as standard of care. FTMH closed after one week. Vision at Month 7 was 6/24.
Fig 3.
Resolution of vitreomacular traction.
The VMT resolution rates at 4, 12 and 24 weeks following a single intravitreal injection of ocriplasmin (0.125 mg in 0.1ml). VMT was diagnosed by OCT as per the classifications provided by the VMT study group.
Table 3.
Anatomical resolution of VMT at 4, 12 and 24 weeks.
Table 4.
Visual acuity at 4, 12 and 24 weeks.